The triterpenoid CDDO-imidazolide ameliorates mouse liver ischemia-reperfusion injury through activating the Nrf2/HO-1 pathway enhanced autophagy
2017 · Cell Death and Disease · 124 citations
https://doi.org/10.1038/cddis.2017.386
X
Xiaoni Kong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
147
Papers
5.7K
Citations
38
h-index
82
i10-index
Xiaoni Kong is an academic researcher from Shanghai University. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Liver physiology and pathology & Drug-Induced Hepatotoxicity and Protection. The author has an h-index of 38, co-authored 125 publications.
ORCID: 0000-0002-1406-051XPapers by this author
worksNon-metabolic role of UCK2 links EGFR-AKT pathway activation to metastasis enhancement in hepatocellular carcinoma
2020 · Oncogenesis · 39 citations
https://doi.org/10.1038/s41389-020-00287-7
Quercetin, a natural flavonoid, protects against hepatic ischemia–reperfusion injury via inhibiting Caspase-8/ASC dependent macrophage pyroptosis
2024 · Journal of Advanced Research · 38 citations
https://doi.org/10.1016/j.jare.2024.05.010
Regulation and functions of NLRP3 inflammasome in cardiac fibrosis: Current knowledge and clinical significance
2021 · Biomedicine & Pharmacotherapy · 33 citations
https://doi.org/10.1016/j.biopha.2021.112219
Shenge Formula attenuates high-fat diet-induced obesity and fatty liver via inhibiting ACOX1
2023 · Phytomedicine · 28 citations
https://doi.org/10.1016/j.phymed.2023.155183
Tumor-associated lymphangiogenesis predicts unfavorable prognosis of intrahepatic cholangiocarcinoma
2019 · BMC Cancer · 26 citations
https://doi.org/10.1186/s12885-019-5420-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat